Collagen Prolyl Hydroxylases Regulate HIF-α Levels Independently of pVHL in ccRCC
Yangsook Song GreeniD, Karen Acuña-Pilarte, Marin Jones, Lily Marie-Therese Halberg, Thai H. HoiD, Mei Yee KohiD
Abstract
The hypoxia-inducible factors, HIF-1 and HIF-2, are master regulators of the hypoxia response. Under ambient conditions, both are hydroxylated by the HIF prolyl hydroxylases (HIF PHDs) resulting in ubiquitination by the pVHL E3 ligase complex, leading to subsequent proteasomal degradation. During hypoxia, the HIF PHDs are inhibited, resulting in HIF- stabilization and transcriptional activation of genes involved in the adaptation to hypoxia. Previous studies have shown that the collagen PHD, P4HA1, which promotes proline hydroxylation of collagen, inhibits the HIF PHDs by modulating levels of -ketoglutarate and succinate, thus enhancing HIF-1 stability by preventing pVHL-mediate degradation. Here, we investigate the role of collagen PHDs in the regulation of HIF-1/2 in the setting of pVHL deficiency in ccRCC. We show that the collagen PHDs P4HA1 and P4HA2 are required for HIF-1 translation and HIF-2 transcription and translation independently of pVHL function, through a mechanism regulated in part by P4HA1/2-driven collagen production. Thus, we reveal a novel pVHL-independent mechanism of HIF-1/2 regulation driven by P4HA1/2 in ccRCC. Since the HIFs have been strongly implicated in ccRCC initiation and progression, our data suggests that inhibition of P4HA1/2 may be a promising therapeutic strategy in ccRCC.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Loss of VHL-mediated pRb regulation promotes clear cell renal cell carcinoma
Mercy Akuma, Minjun Kim, … Ryan Charles Russell·Cell Death and DiseasePeer-reviewed·Apr 16, 2025
- Hypoxia-inducible factors drive miRNA-mediated downregulation of L2HGDH and HIF1A in clear cell renal cancer independent of 14q deletion
Soma Seal, Rebecca A. Luchtel, … Niraj Konchady Shenoy·bioRxiv·Dec 1, 2024
- Hypoxia modulates human pulmonary arterial adventitial fibroblast phenotype through HIF-1α activation
Jennifer L. Philip, Christine A. Caneba, … Naomi C. Chesler·bioRxiv·Jan 27, 2025
- SET1B drives sustained HIF activity and disease progression in clear cell renal cell carcinoma.
Brian M. Ortmann, Tekle Pauzaite, … James A. Nathan·Cancer ResearchPeer-reviewed·Apr 6, 2026
- ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma
Y. Song Green, M. C. Ferreira dos Santos, … M. Y. Koh·bioRxiv·Jun 1, 2022
- Erythrocytosis-inducing PHD2 mutations implicate biological role for N-terminal prolyl-hydroxylation in HIF1α oxygen-dependent degradation domain
Cassandra Carol Taber, Wenguang He, … Michael Ohh·bioRxiv·Apr 22, 2025